Online First

Survey Report
Evolution of Hematopoietic Stem Cell Transplant Programs in Malaysia
Norashikin Saidon1, Nur Adila Anuar2, Chang Kian Meng3, Ong Tee Chuan4, Tan Sen Mui4, Gan Gin Gin2, Fadilah SAW5, Hany Ariffin6, Lin Hai Peng7, Chan Lee Lee7, Alan Teh7, Bee Ping Chong2

1Faculty of Medicine, Sungai Buloh, Universiti Teknologi MARA, Malaysia,

2Hematology Unit, University of Malaya Medical Center, Malaysia,

3Sunway Medical Center, Malaysia,

4Hematology Department, Hospital Ampang, Malaysia,

5Department of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Malaysia,

6Department of Pediatrics, University of Malaya Medical Center, Malaysia,

7Subang Jaya Medical Center, Malaysia

hematopoietic stem cell transplant, Malaysia, allogeneic, autologous, haploidentical
Submitted:December 3, 2019
Accepted:March 6, 2020
Published online:June 10, 2020


Hematopoietic stem cell transplantation (HSCT) is now widely practiced worldwide. It has the potential to cure many hematological diseases, such as acute leukemia and thalassemia. As an emerging country, Malaysia has made advancements despite many challenges. HSCT has evolved rapidly since the first pediatric allogeneic HSCT case in 1987. The first adult HSCT was performed 5 years later in 1993. Currently, a total of 13 hospitals offer HSCT services throughout Malaysia. These include private healthcare services, substantially funded government hospitals governed by the Ministry of Health, and partially funded teaching hospitals governed by the Ministry of Education. Until 2015, 1,987 allogeneic and 1,648 autologous HSCT procedures were performed. This article narrates the history and development of HSCT in Malaysia and briefly discusses the challenging issues in this area.



Online ISSN:2432-7026